New Guidelines for First-Line Chemo Against Advanced Ovarian Cancer Issued

New Guidelines for First-Line Chemo Against Advanced Ovarian Cancer Issued
According to a new clinical guideline jointly created by the American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology, some women with advanced ovarian cancer should receive neoadjuvant chemotherapy as first-line treatment instead of the standard of care, primary cytoreduction surgery. The guideline was recently published in the Journal of Clinical Oncology, under the title “Neoadjuvant Chemotherapy

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *